☰
×
News
Top 20
Insights
Insights+
ThoughtSpot
Interviews
Viewpoints
Exclusive
Spotlight
Events
Magazine
Bespoke
Newswire
x
Search
Search here
Search here
Subscribe Now
Numab
Numab Entered into a Development and License Agreement with Ono to Develop Immuno-Oncology Therapies for the Treatment of Cancer
March 31, 2022
Load more...
Back to Home
Modal title
×
Modal body text goes here.